Table 1 Demographic, comorbidity, prescription drug use characteristics of sample, by substance use type.
From: Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study
| Ā | Stimulant use only N(%) | Opioid use only N(%) | Both N(%) | Total N(%) | P value |
|---|---|---|---|---|---|
2837 (38Ā·0) | 2901(38Ā·9) | 1722 (23Ā·1) | 7460 | ||
Demographics | |||||
Sex | |||||
āFemale | 1017(35Ā·8) | 1202(41Ā·4) | 681(39Ā·5) | 2900(38Ā·9) | <ā0Ā·001 |
āMale | 1820(64Ā·2) | 1699(58Ā·6) | 1041(60Ā·5) | 4560(61Ā·1) | Ā |
Age | |||||
āā<ā30 | 866(30Ā·5) | 593(20Ā·4) | 477(27Ā·7) | 1936(26Ā·0) | <ā0Ā·001 |
ā30-39 | 780(27Ā·5) | 716(24Ā·7) | 514(29Ā·8) | 2010(26Ā·9) | Ā |
ā40-49 | 610(21Ā·5) | 586(20Ā·2) | 392(22Ā·8) | 1588(21Ā·3) | Ā |
ā50+ | 581(20Ā·5) | 1006(34Ā·7) | 339(19Ā·7) | 1926(25Ā·8) | Ā |
Health authority of residence | |||||
āVancouver Costal | 733(25Ā·8) | 645(22Ā·2) | 691(40Ā·1) | 2069(27Ā·7) | <ā0Ā·001 |
āVancouver Island | 383(13Ā·5) | 598(20Ā·6) | 153(8Ā·9) | 1134(15Ā·2) | Ā |
āFraser | 886(31Ā·2) | 892(30Ā·7) | 539(31Ā·9) | 2317(31Ā·1) | Ā |
āInterior | 517(18Ā·2) | 468(16Ā·1) | 239(13Ā·9) | 1224(16Ā·4) | Ā |
āNorthern | 285(10Ā·0) | 156(5Ā·4) | 90(5Ā·2) | 531(7Ā·1) | Ā |
āUnknown | 33(1Ā·2) | 142(4Ā·9) | 10(0Ā·6) | 185(2.5) | Ā |
Comorbidities | |||||
Elixhauser index | |||||
ā0 | 1004(35Ā·4) | 1630(56Ā·2) | 531(30Ā·8) | 3165(42Ā·4) | <ā0Ā·001 |
ā1 | 544(19Ā·2) | 509(17Ā·5) | 359(20Ā·8) | 1412(18Ā·9) | Ā |
ā2 | 635(22Ā·4) | 296(10Ā·2) | 362(21Ā·0) | 1293(17Ā·3) | Ā |
ā3+ | 654(23Ā·1) | 466(16Ā·1) | 470(27Ā·3) | 1590(21Ā·3) | Ā |
Prescribed medications (Prior 30ādays at baseline) | |||||
āBenzodiazepines | 305(10Ā·8) | 447(15Ā·4) | 243(14Ā·1) | 995(13Ā·3) | <ā0Ā·001 |
āZ drugs | 139(4Ā·9) | 209(7Ā·2) | 110(6Ā·4) | 458(6Ā·1) | 0Ā·001 |
āSedatives | 1036(36Ā·5) | 2150(74Ā·1) | 1079(62Ā·7) | 4265(57Ā·2) | <ā0Ā·001 |
āOpioids for pain | 256(9Ā·0) | 797(27Ā·5) | 269(15Ā·6) | 1322(17Ā·7) | <ā0Ā·001 |